Your browser doesn't support javascript.
loading
Factors Associated With Circulating Sex Hormones in Men : Individual Participant Data Meta-analyses.
Marriott, Ross J; Murray, Kevin; Adams, Robert J; Antonio, Leen; Ballantyne, Christie M; Bauer, Douglas C; Bhasin, Shalender; Biggs, Mary L; Cawthon, Peggy M; Couper, David J; Dobs, Adrian S; Flicker, Leon; Handelsman, David J; Hankey, Graeme J; Hannemann, Anke; Haring, Robin; Hsu, Benjumin; Karlsson, Magnus; Martin, Sean A; Matsumoto, Alvin M; Mellström, Dan; Ohlsson, Claes; O'Neill, Terence W; Orwoll, Eric S; Quartagno, Matteo; Shores, Molly M; Steveling, Antje; Tivesten, Åsa; Travison, Thomas G; Vanderschueren, Dirk; Wittert, Gary A; Wu, Frederick C W; Yeap, Bu B.
Affiliation
  • Marriott RJ; School of Population and Global Health, University of Western Australia, Perth, Western Australia, Australia (R.J.M., K.M.).
  • Murray K; School of Population and Global Health, University of Western Australia, Perth, Western Australia, Australia (R.J.M., K.M.).
  • Adams RJ; Adelaide Institute for Sleep Health, Flinders University, Bedford Park, South Australia, Australia (R.J.A.).
  • Antonio L; Laboratory of Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium (L.A., D.V.).
  • Ballantyne CM; Internal Medicine, Baylor College of Medicine, Houston, Texas (C.M.B.).
  • Bauer DC; General Internal Medicine, University of California, San Francisco, San Francisco, California (D.C.B.).
  • Bhasin S; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (S.B.).
  • Biggs ML; Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington (M.L.B.).
  • Cawthon PM; San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, California (P.M.C.).
  • Couper DJ; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (D.J.C.).
  • Dobs AS; School of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, Baltimore, Maryland (A.S.D.).
  • Flicker L; Medical School and Western Australian Centre for Health and Ageing, University of Western Australia, Perth, Western Australia, Australia (L.F.).
  • Handelsman DJ; ANZAC Research Institute, University of Sydney, Sydney, New South Wales, Australia (D.J.H.).
  • Hankey GJ; Medical School, University of Western Australia, and Perron Institute for Neurological and Translational Science, Perth, Western Australia, Australia (G.J.H.).
  • Hannemann A; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, and DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany (A.H.).
  • Haring R; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia, and Faculty of Applied Public Health, European University of Applied Sciences, Rostock, Germany (R.H.).
  • Hsu B; Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia (B.H.).
  • Karlsson M; Clinical and Molecular Osteoporosis Research Unit, Departments of Orthopedics and Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden (M.K.).
  • Martin SA; Australian Institute of Family Studies, Southbank, Victoria, Australia (S.A.M.).
  • Matsumoto AM; Department of Medicine, University of Washington School of Medicine, and Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington (A.M.M.).
  • Mellström D; Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Institute of Medicine, University of Gothenburg, Göteborg, Sweden (D.M., C.O.).
  • Ohlsson C; Centre for Bone and Arthritis Research at the Sahlgrenska Academy, Institute of Medicine, University of Gothenburg, Göteborg, Sweden (D.M., C.O.).
  • O'Neill TW; Centre for Epidemiology Versus Arthritis, University of Manchester and National Institute for Health and Care Research Manchester Biomedical Research Centre, Manchester University National Health Service Foundation Trust, Manchester, United Kingdom (T.W.O.).
  • Orwoll ES; Oregon Health & Science University, Portland, Oregon (E.S.O.).
  • Quartagno M; Medical Research Council Clinical Trials Unit, University College London, London, United Kingdom (M.Q.).
  • Shores MM; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, Washington (M.M.S.).
  • Steveling A; Department of Internal Medicine, University Medicine Greifswald, Greifswald, Germany (A.S.).
  • Tivesten Å; Wallenberg Laboratory for Cardiovascular and Metabolic Research, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, and Department of Endocrinology, Sahlgrenska University Hospital, Region Västra Götaland, Göteborg, Sweden (Å.T.).
  • Travison TG; Brigham and Women's Hospital and Institute for Aging Research, Hebrew SeniorLife, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts (T.G.T.).
  • Vanderschueren D; Laboratory of Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, Leuven, Belgium (L.A., D.V.).
  • Wittert GA; Freemasons Centre for Male Health & Wellbeing, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia (G.A.W.).
  • Wu FCW; Division of Endocrinology, Diabetes & Gastroenterology, School of Medical Sciences, University of Manchester, Manchester, United Kingdom (F.C.W.W.).
  • Yeap BB; Medical School, University of Western Australia, and Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Western Australia, Perth, Australia (B.B.Y.).
Ann Intern Med ; 176(9): 1221-1234, 2023 09.
Article in En | MEDLINE | ID: mdl-37639720
ABSTRACT

BACKGROUND:

Various factors modulate circulating testosterone in men, affecting interpretation of testosterone measurements.

PURPOSE:

To clarify factors associated with variations in sex hormone concentrations. DATA SOURCES Systematic literature searches (to July 2019). STUDY SELECTION Prospective cohort studies of community-dwelling men with total testosterone measured using mass spectrometry. DATA EXTRACTION Individual participant data (IPD) (9 studies; n = 21 074) and aggregate data (2 studies; n = 4075). Sociodemographic, lifestyle, and health factors and concentrations of total testosterone, sex hormone-binding globulin (SHBG), luteinizing hormone (LH), dihydrotestosterone, and estradiol were extracted. DATA

SYNTHESIS:

Two-stage random-effects IPD meta-analyses found a nonlinear association of testosterone with age, with negligible change among men aged 17 to 70 years (change per SD increase about the midpoint, -0.27 nmol/L [-7.8 ng/dL] [CI, -0.71 to 0.18 nmol/L {-20.5 to 5.2 ng/dL}]) and decreasing testosterone levels with age for men older than 70 years (-1.55 nmol/L [-44.7 ng/dL] [CI, -2.05 to -1.06 nmol/L {-59.1 to -30.6 ng/dL}]). Testosterone was inversely associated with body mass index (BMI) (change per SD increase, -2.42 nmol/L [-69.7 ng/dL] [CI, -2.70 to -2.13 nmol/L {-77.8 to -61.4 ng/dL}]). Testosterone concentrations were lower for men who were married (mean difference, -0.57 nmol/L [-16.4 ng/dL] [CI, -0.89 to -0.26 nmol/L {-25.6 to -7.5 ng/dL}]); undertook at most 75 minutes of vigorous physical activity per week (-0.51 nmol/L [-14.7 ng/dL] [CI, -0.90 to -0.13 nmol/L {-25.9 to -3.7 ng/dL}]); were former smokers (-0.34 nmol/L [-9.8 ng/dL] [CI, -0.55 to -0.12 nmol/L {-15.9 to -3.5 ng/dL}]); or had hypertension (-0.53 nmol/L [-15.3 ng/dL] [CI, -0.82 to -0.24 nmol/L {-23.6 to -6.9 ng/dL}]), cardiovascular disease (-0.35 nmol/L [-10.1 ng/dL] [CI, -0.55 to -0.15 nmol/L {-15.9 to -4.3 ng/dL}]), cancer (-1.39 nmol/L [-40.1 ng/dL] [CI, -1.79 to -0.99 nmol/L {-51.6 to -28.5 ng/dL}]), or diabetes (-1.43 nmol/L [-41.2 ng/dL] [CI, -1.65 to -1.22 nmol/L {-47.6 to -35.2 ng/dL}]). Sex hormone-binding globulin was directly associated with age and inversely associated with BMI. Luteinizing hormone was directly associated with age in men older than 70 years.

LIMITATION:

Cross-sectional analysis, heterogeneity between studies and in timing of blood sampling, and imputation for missing data.

CONCLUSION:

Multiple factors are associated with variation in male testosterone, SHBG, and LH concentrations. Reduced testosterone and increased LH concentrations may indicate impaired testicular function after age 70 years. Interpretation of individual testosterone measurements should account particularly for age older than 70 years, obesity, diabetes, and cancer. PRIMARY FUNDING SOURCE Medical Research Future Fund, Government of Western Australia, and Lawley Pharmaceuticals. (PROSPERO CRD42019139668).
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gonadal Steroid Hormones / Sex Hormone-Binding Globulin Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Humans / Male / Middle aged Language: En Journal: Ann Intern Med Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gonadal Steroid Hormones / Sex Hormone-Binding Globulin Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Humans / Male / Middle aged Language: En Journal: Ann Intern Med Year: 2023 Document type: Article